Radiotherapy is an effective treatment for aggressive bladder cancer and could spare patients surgery that removes the whole bladder, according to a study published in this month's International Journal of Radiation Oncology Biology Physics.
The Cancer Research UK study found that two different approaches to giving radiotherapy controlled the disease and had a low risk of severe side effects.
This part of the BC2001 radiotherapy study, led by researchers at The Institute of Cancer Research, London, and the University of Birmingham, compared giving radiotherapy to the whole bladder with targeted radiotherapy focused on the tumour.
Both types of treatment prevented the tumour from returning for over 60 per cent of patients for at least two years. And for many whose disease returned, it was not aggressive and only needed local treatment.
After five years of follow-up the survival rates were around 40 per cent for both radiotherapy approaches, a figure comparable to patients who have surgery to remove their bladder. In addition, patients receiving either type of radiotherapy had a low risk of severe side effects.
The standard treatment for aggressive bladder cancer is to remove the bladder. This can cause severe side effects and usually results in patients wearing a plastic bag to collect urine.
Dr Robert Huddart, lead investigator of the study based at The Institute of Cancer Research, London, said: "Our study was part of the largest ever clinical trial of radiotherapy in bladder cancer and shows that patients with the disease can be treated effectively with radiotherapy. With similar success rates to surgery and fewer side effects whilst allowing patients to retain a functioning bladder, radiotherapy should be seen as an alternative to surgery.
"The introduction of image guided radiotherapy and more sophisticated ways of giving radiotherapy will hopefully further reduce any side effects that patients experience."
Kate Law, director of clinical research at Cancer Research UK, said: "Previous results from this trial changed how doctors treat bladder cancer, showing that giving patients chemotherapy and radiotherapy is better than radiotherapy alone. Many thousands of patients take part in Cancer Research UK-funded clinical trials every year, and it's only by carrying out studies like this that we can test different approaches to find the most effective and safest treatments."
Explore further: Bladder cancer patients over 70 less likely to get curative treatment
More information: Huddart, R et al Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004) International Journal of Radiation Oncology biology physics (2013)
Medical Xpress on facebook
Related Stories
Bladder cancer patients over 70 less likely to get curative treatment
Apr 17, 2013
(Medical Xpress)—Older bladder cancer patients are less likely than younger patients to receive treatments intended to cure their disease such as surgery to remove the bladder or radiotherapy. But this difference cannot ...
Accelerated radiotherapy more efficient than current practice
Sep 04, 2013
Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the ...
New treatment to reduce the relapse rate in bladder cancer patients
Jan 31, 2011
(PhysOrg.com) -- A major bladder cancer trial, funded by Cancer Research UK, has shown that adding two commonly used chemotherapy drugs to traditional radiotherapy can reduce the chance of a patient's tumour coming back by ...
Adding chemo to radiotherapy halves risk of deadly bladder cancer returning
Apr 23, 2012
(Phys.org) -- Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to patients given radiotherapy ...
Breast conserving treatment with radiotherapy reduces risk of local recurrence
Sep 18, 2013
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcin ...
Recommended for you
Scientists build a microscope to spot the seeds of cancer
1 hour ago
(Medical Xpress)—Cancerous tumors can shed cells that travel through the blood stream and create new cancerous growths. These seed cells can be very difficult to detect, but Stanford scientists are developing ...
Study finds link between high-fat, high-calorie diet and pancreas cancer
1 hour ago
(Medical Xpress)—Researchers at UCLA's Jonsson Comprehensive Cancer Center have found that mice made obese by high-calorie, high-fat diets develop abnormally high numbers of lesions known to be precursors to pancreas cancer.
Genetic markings could spot cancer before it develops
7 hours ago
Unique DNA markings on certain genes may "predict" the risk of developing head and neck cancer, according to new research led by Queen Mary University of London.
New study shows blood test detected cancer metastasis
13 hours ago
Researchers from the University Göttingen Institute of Veterinary Medicine and Chronix Biomedical have published a new study exploring the genetic hallmarks of canine mammary cancer. Appearing in the peer-reviewed journal ...
What works for women doesn't work for men
15 hours ago
Flushed face, sweating, a sudden rush of heat. The hot flash, the bane of menopausal women, also can affect men who are undergoing hormone therapy for prostate cancer.
Cancer biggest killer of Hispanic Texans
19 hours ago
More Hispanic Texans die from cancer than any other cause, according to a new report by the Comparative Effectiveness Research on Cancer in Texas research group.
User comments
© Medical Xpress 2011-2013, Phys.org network
Radiotherapy is an effective treatment for aggressive bladder cancer and could spare patients surgery that removes the whole bladder, according to a study published in this month's International Journal of Radiation Oncology Biology Physics.
The Cancer Research UK study found that two different approaches to giving radiotherapy controlled the disease and had a low risk of severe side effects.
This part of the BC2001 radiotherapy study, led by researchers at The Institute of Cancer Research, London, and the University of Birmingham, compared giving radiotherapy to the whole bladder with targeted radiotherapy focused on the tumour.
Both types of treatment prevented the tumour from returning for over 60 per cent of patients for at least two years. And for many whose disease returned, it was not aggressive and only needed local treatment.
After five years of follow-up the survival rates were around 40 per cent for both radiotherapy approaches, a figure comparable to patients who have surgery to remove their bladder. In addition, patients receiving either type of radiotherapy had a low risk of severe side effects.
The standard treatment for aggressive bladder cancer is to remove the bladder. This can cause severe side effects and usually results in patients wearing a plastic bag to collect urine.
Dr Robert Huddart, lead investigator of the study based at The Institute of Cancer Research, London, said: "Our study was part of the largest ever clinical trial of radiotherapy in bladder cancer and shows that patients with the disease can be treated effectively with radiotherapy. With similar success rates to surgery and fewer side effects whilst allowing patients to retain a functioning bladder, radiotherapy should be seen as an alternative to surgery.
"The introduction of image guided radiotherapy and more sophisticated ways of giving radiotherapy will hopefully further reduce any side effects that patients experience."
Kate Law, director of clinical research at Cancer Research UK, said: "Previous results from this trial changed how doctors treat bladder cancer, showing that giving patients chemotherapy and radiotherapy is better than radiotherapy alone. Many thousands of patients take part in Cancer Research UK-funded clinical trials every year, and it's only by carrying out studies like this that we can test different approaches to find the most effective and safest treatments."
Explore further: Bladder cancer patients over 70 less likely to get curative treatment
More information: Huddart, R et al Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004) International Journal of Radiation Oncology biology physics (2013)
Medical Xpress on facebook
Related Stories
Bladder cancer patients over 70 less likely to get curative treatment
Apr 17, 2013
(Medical Xpress)—Older bladder cancer patients are less likely than younger patients to receive treatments intended to cure their disease such as surgery to remove the bladder or radiotherapy. But this difference cannot ...
Accelerated radiotherapy more efficient than current practice
Sep 04, 2013
Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the ...
New treatment to reduce the relapse rate in bladder cancer patients
Jan 31, 2011
(PhysOrg.com) -- A major bladder cancer trial, funded by Cancer Research UK, has shown that adding two commonly used chemotherapy drugs to traditional radiotherapy can reduce the chance of a patient's tumour coming back by ...
Adding chemo to radiotherapy halves risk of deadly bladder cancer returning
Apr 23, 2012
(Phys.org) -- Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to patients given radiotherapy ...
Breast conserving treatment with radiotherapy reduces risk of local recurrence
Sep 18, 2013
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcin ...
Recommended for you
Scientists build a microscope to spot the seeds of cancer
1 hour ago
(Medical Xpress)—Cancerous tumors can shed cells that travel through the blood stream and create new cancerous growths. These seed cells can be very difficult to detect, but Stanford scientists are developing ...
Study finds link between high-fat, high-calorie diet and pancreas cancer
1 hour ago
(Medical Xpress)—Researchers at UCLA's Jonsson Comprehensive Cancer Center have found that mice made obese by high-calorie, high-fat diets develop abnormally high numbers of lesions known to be precursors to pancreas cancer.
Genetic markings could spot cancer before it develops
7 hours ago
Unique DNA markings on certain genes may "predict" the risk of developing head and neck cancer, according to new research led by Queen Mary University of London.
New study shows blood test detected cancer metastasis
13 hours ago
Researchers from the University Göttingen Institute of Veterinary Medicine and Chronix Biomedical have published a new study exploring the genetic hallmarks of canine mammary cancer. Appearing in the peer-reviewed journal ...
What works for women doesn't work for men
15 hours ago
Flushed face, sweating, a sudden rush of heat. The hot flash, the bane of menopausal women, also can affect men who are undergoing hormone therapy for prostate cancer.
Cancer biggest killer of Hispanic Texans
19 hours ago
More Hispanic Texans die from cancer than any other cause, according to a new report by the Comparative Effectiveness Research on Cancer in Texas research group.
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment